WO2022150759A1 - Antibodies targeted to cd147 - Google Patents

Antibodies targeted to cd147 Download PDF

Info

Publication number
WO2022150759A1
WO2022150759A1 PCT/US2022/011969 US2022011969W WO2022150759A1 WO 2022150759 A1 WO2022150759 A1 WO 2022150759A1 US 2022011969 W US2022011969 W US 2022011969W WO 2022150759 A1 WO2022150759 A1 WO 2022150759A1
Authority
WO
WIPO (PCT)
Prior art keywords
antibody
cancer
cell
virus
hours
Prior art date
Application number
PCT/US2022/011969
Other languages
French (fr)
Inventor
Vidal Felix DE LA CRUZ
Alberto Murat CROCI
Michael Joseph KARLIN
Original Assignee
Ibex Biosciences, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US202163135827P priority Critical
Priority to US63/135,827 priority
Application filed by Ibex Biosciences, Llc filed Critical Ibex Biosciences, Llc
Publication of WO2022150759A1 publication Critical patent/WO2022150759A1/en

Links